Back to Journals » Drug Design, Development and Therapy » Volume 10

Paclitaxel plus valproic acid versus paclitaxel alone as second- or third-line therapy for advanced gastric cancer: a randomized Phase II trial

Total article views   HTML views PDF downloads Totals
9,394 Dovepress* 8,456+ 1,340 9,796
PubMed Central* 938 349 1,287
Totals 9,394 1,689 11,083
*Since 25 July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar